Scholar Rock Holding Corp
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to deve… Read more
Scholar Rock Holding Corp (SRRK) - Net Assets
Latest net assets as of September 2025: $245.00 Million USD
Based on the latest financial reports, Scholar Rock Holding Corp (SRRK) has net assets worth $245.00 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($411.72 Million) and total liabilities ($166.72 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $245.00 Million |
| % of Total Assets | 59.51% |
| Annual Growth Rate | N/A |
| 5-Year Change | 41.36% |
| 10-Year Change | N/A |
| Growth Volatility | 55.15 |
Scholar Rock Holding Corp - Net Assets Trend (2016–2024)
This chart illustrates how Scholar Rock Holding Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Scholar Rock Holding Corp (2016–2024)
The table below shows the annual net assets of Scholar Rock Holding Corp from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $368.63 Million | +63.68% |
| 2023-12-31 | $225.22 Million | -13.46% |
| 2022-12-31 | $260.24 Million | +51.23% |
| 2021-12-31 | $172.07 Million | -34.01% |
| 2020-12-31 | $260.77 Million | +130.97% |
| 2019-12-31 | $112.90 Million | +5.89% |
| 2018-12-31 | $106.62 Million | +299.21% |
| 2017-12-31 | $-53.52 Million | -78.25% |
| 2016-12-31 | $-30.03 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Scholar Rock Holding Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 89018500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $94.00K | 0.03% |
| Other Comprehensive Income | $160.00K | 0.04% |
| Other Components | $1.29 Billion | 350.24% |
| Total Equity | $368.63 Million | 100.00% |
Scholar Rock Holding Corp Competitors by Market Cap
The table below lists competitors of Scholar Rock Holding Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Oceaneering International Inc
NYSE:OII
|
$3.39 Billion |
|
HUAYU Automotive Systems Co Ltd
SHG:600741
|
$3.40 Billion |
|
Jl Mag Rare-Earth Co Ltd Class A
SHE:300748
|
$3.40 Billion |
|
Gitlab Inc
NASDAQ:GTLB
|
$3.40 Billion |
|
Qualys Inc
NASDAQ:QLYS
|
$3.38 Billion |
|
Samsung Engineering
KO:028050
|
$3.38 Billion |
|
FSN E-Commerce Ventures Limited
NSE:NYKAA
|
$3.38 Billion |
|
Zhejiang Shuanghuan Driveline Co Ltd
SHE:002472
|
$3.37 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Scholar Rock Holding Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 225,218,000 to 368,634,000, a change of 143,416,000 (63.7%).
- Net loss of 246,294,000 reduced equity.
- New share issuances of 324,414,000 increased equity.
- Other comprehensive income increased equity by 68,000.
- Other factors increased equity by 65,228,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-246.29 Million | -66.81% |
| Share Issuances | $324.41 Million | +88.0% |
| Other Comprehensive Income | $68.00K | +0.02% |
| Other Changes | $65.23 Million | +17.69% |
| Total Change | $- | 63.68% |
Book Value vs Market Value Analysis
This analysis compares Scholar Rock Holding Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 11.03x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $-1.68 | $40.71 | x |
| 2017-12-31 | $-2.99 | $40.71 | x |
| 2018-12-31 | $6.81 | $40.71 | x |
| 2019-12-31 | $4.10 | $40.71 | x |
| 2020-12-31 | $8.48 | $40.71 | x |
| 2021-12-31 | $4.69 | $40.71 | x |
| 2022-12-31 | $4.37 | $40.71 | x |
| 2023-12-31 | $2.96 | $40.71 | x |
| 2024-12-31 | $3.69 | $40.71 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Scholar Rock Holding Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -66.81%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.29x
- Recent ROE (-66.81%) is below the historical average (-43.39%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | -4276.25% | 0.01x | 0.00x | $-13.20 Million |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-19.64 Million |
| 2018 | -46.26% | 0.00% | 0.00x | 1.70x | $-59.99 Million |
| 2019 | -44.02% | -242.52% | 0.10x | 1.74x | $-60.99 Million |
| 2020 | -32.59% | -551.79% | 0.04x | 1.49x | $-111.07 Million |
| 2021 | -76.59% | -700.46% | 0.06x | 1.77x | $-149.01 Million |
| 2022 | -50.59% | -396.61% | 0.09x | 1.38x | $-157.67 Million |
| 2023 | -73.61% | 0.00% | 0.00x | 1.38x | $-188.31 Million |
| 2024 | -66.81% | 0.00% | 0.00x | 1.29x | $-283.16 Million |
Industry Comparison
This section compares Scholar Rock Holding Corp's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $59,082,939
- Average return on equity (ROE) among peers: -341.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Scholar Rock Holding Corp (SRRK) | $245.00 Million | 0.00% | 0.68x | $3.39 Billion |
| Aadi Bioscience Inc (AADI) | $-124.24K | 0.00% | 0.00x | $17.03 Million |
| America Great Health (AAGH) | $-992.37K | 0.00% | 0.00x | $2.12 Million |
| Ascentage Pharma Group International (AAPG) | $70.63 Million | -1310.51% | 34.40x | $2.25 Billion |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $59.18 Million |
| ABIVAX Société Anonyme (AAVXF) | $196.01 Million | -75.37% | 0.67x | $377.86 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $738.02 Million |
| Abeona Therapeutics Inc (ABEO) | $489.00K | -1919.02% | 38.85x | $202.79 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $188.78 Million | -22.70% | 0.04x | $108.65 Million |
| Abpro Holdings, Inc. (ABP) | $-22.46 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $176.18 Million | -62.76% | 0.23x | $345.85 Million |